2024 Q1 Form 10-Q Financial Statement
#000143774924003522 Filed on February 08, 2024
Income Statement
Concept | 2024 Q1 | 2023 Q4 | 2022 Q4 |
---|---|---|---|
Revenue | $6.940M | $6.144M | $6.145M |
YoY Change | 17.31% | -0.02% | -27.99% |
Cost Of Revenue | $1.046M | $911.0K | $969.0K |
YoY Change | 12.47% | -5.99% | -48.38% |
Gross Profit | $5.894M | $5.233M | $5.176M |
YoY Change | 18.21% | 1.1% | -22.25% |
Gross Profit Margin | 84.93% | 85.17% | 84.23% |
Selling, General & Admin | $3.918M | $3.739M | $3.522M |
YoY Change | 17.38% | 6.16% | -7.73% |
% of Gross Profit | 66.47% | 71.45% | 68.04% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $57.00K | $69.00K | $49.00K |
YoY Change | 1.79% | 40.82% | -7.55% |
% of Gross Profit | 0.97% | 1.32% | 0.95% |
Operating Expenses | $5.021M | $4.719M | $4.540M |
YoY Change | 16.12% | 3.94% | 17.31% |
Operating Profit | $1.919M | $1.425M | $1.605M |
YoY Change | 20.54% | -11.21% | -42.41% |
Interest Expense | $568.0K | $567.0K | $563.0K |
YoY Change | 1.07% | 0.71% | -210.83% |
% of Operating Profit | 29.6% | 39.79% | 35.08% |
Other Income/Expense, Net | $467.0K | ||
YoY Change | 23250.0% | ||
Pretax Income | $2.122M | $1.644M | $1.509M |
YoY Change | 31.8% | 8.95% | -33.84% |
Income Tax | $582.0K | $444.0K | $390.0K |
% Of Pretax Income | 27.43% | 27.01% | 25.84% |
Net Earnings | $1.540M | $1.200M | $1.119M |
YoY Change | 28.87% | 7.24% | -41.51% |
Net Earnings / Revenue | 22.19% | 19.53% | 18.21% |
Basic Earnings Per Share | $0.20 | $0.16 | $0.15 |
Diluted Earnings Per Share | $0.20 | $0.16 | $0.15 |
COMMON SHARES | |||
Basic Shares Outstanding | 7.675M | 7.674M | 7.574M |
Diluted Shares Outstanding | 7.700M | 7.674M | 7.581M |
Balance Sheet
Concept | 2024 Q1 | 2023 Q4 | 2022 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $59.60M | $59.62M | $57.06M |
YoY Change | 2.98% | 4.48% | 4.67% |
Cash & Equivalents | $59.59M | $59.61M | $57.05M |
Short-Term Investments | $11.00K | $11.00K | $10.00K |
Other Short-Term Assets | $732.0K | $603.0K | $762.0K |
YoY Change | -16.82% | -20.87% | 35.35% |
Inventory | |||
Prepaid Expenses | $732.0K | $603.0K | $762.0K |
Receivables | $2.556M | $2.155M | $2.075M |
Other Receivables | $273.0K | $251.0K | $257.0K |
Total Short-Term Assets | $63.43M | $62.89M | $60.15M |
YoY Change | 4.07% | 4.55% | 3.2% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $295.0K | $282.0K | $335.0K |
YoY Change | -10.06% | -15.82% | -72.87% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $182.0K | $163.0K | $157.0K |
YoY Change | 15.92% | 3.82% | -36.18% |
Total Long-Term Assets | $83.91M | $82.12M | $82.07M |
YoY Change | 2.29% | 0.06% | -0.07% |
TOTAL ASSETS | |||
Total Short-Term Assets | $63.43M | $62.89M | $60.15M |
Total Long-Term Assets | $83.91M | $82.12M | $82.07M |
Total Assets | $147.3M | $145.0M | $142.2M |
YoY Change | 3.05% | 1.96% | 1.29% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $672.0K | $745.0K | $1.737M |
YoY Change | -68.77% | -57.11% | -38.51% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $3.169M | $2.780M | $2.685M |
YoY Change | 20.27% | 3.54% | -26.9% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $39.32M | $39.24M | $38.94M |
YoY Change | 0.78% | 0.76% | 0.73% |
Other Long-Term Liabilities | $864.0K | $186.0K | |
YoY Change | 829.03% | -66.43% | |
Total Long-Term Liabilities | $40.18M | $39.24M | $39.13M |
YoY Change | 2.75% | 0.28% | -0.22% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $3.169M | $2.780M | $2.685M |
Total Long-Term Liabilities | $40.18M | $39.24M | $39.13M |
Total Liabilities | $58.41M | $56.85M | $55.56M |
YoY Change | 4.52% | 2.31% | -0.59% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $66.58M | $66.10M | $65.43M |
YoY Change | 1.53% | 1.03% | |
Common Stock | $22.34M | $22.06M | $21.23M |
YoY Change | 3.86% | 3.93% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $88.92M | $88.16M | $86.66M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $147.3M | $145.0M | $142.2M |
YoY Change | 3.05% | 1.96% | 1.29% |
Cashflow Statement
Concept | 2024 Q1 | 2023 Q4 | 2022 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $1.540M | $1.200M | $1.119M |
YoY Change | 28.87% | 7.24% | -41.51% |
Depreciation, Depletion And Amortization | $57.00K | $69.00K | $49.00K |
YoY Change | 1.79% | 40.82% | -7.55% |
Cash From Operating Activities | $1.873M | $416.0K | -$32.00K |
YoY Change | -5.74% | -1400.0% | -102.76% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $860.0K | $46.00K | $64.00K |
YoY Change | 493.1% | -28.13% | -212.28% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$860.0K | -$250.0K | -$381.0K |
YoY Change | 493.1% | -34.38% | 568.42% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | $1.038M | $1.026M | |
YoY Change | 1.17% | 1.79% | |
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -1.025M | -$1.037M | -1.024M |
YoY Change | 0.2% | 1.27% | -102.73% |
NET CHANGE | |||
Cash From Operating Activities | 1.873M | $416.0K | -32.00K |
Cash From Investing Activities | -860.0K | -$250.0K | -381.0K |
Cash From Financing Activities | -1.025M | -$1.037M | -1.024M |
Net Change In Cash | -12.00K | -$871.0K | -1.437M |
YoY Change | -101.47% | -39.39% | -103.72% |
FREE CASH FLOW | |||
Cash From Operating Activities | $1.873M | $416.0K | -$32.00K |
Capital Expenditures | $860.0K | $46.00K | $64.00K |
Free Cash Flow | $1.013M | $370.0K | -$96.00K |
YoY Change | -45.01% | -485.42% | -107.89% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q4 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q4 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--09-30 | |
CY2023Q4 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2023Q4 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2356000 | usd |
CY2023Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2287000 | usd |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q4 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
0 | |
CY2023Q3 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
0 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
22500000 | |
CY2023Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
22500000 | |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7673869 | |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7673869 | |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7671099 | |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7671099 | |
CY2023Q4 | us-gaap |
Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
|
2023-11-13 | |
CY2023Q4 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2023Q4 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2023Q4 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2023Q4 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2023Q4 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q4 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q4 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023Q4 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q4 | dei |
Entity File Number
EntityFileNumber
|
001-36423 | |
CY2023Q4 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
CA | |
CY2023Q4 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
68-0176227 | |
CY2023Q4 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
7250 Redwood Boulevard, Suite 200 | |
CY2023Q4 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Novato | |
CY2023Q4 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | |
CY2023Q4 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
94945 | |
CY2023Q4 | dei |
City Area Code
CityAreaCode
|
415 | |
CY2023Q4 | dei |
Local Phone Number
LocalPhoneNumber
|
899-1555 | |
CY2023Q4 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q4 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023Q4 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023Q4 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q4 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023Q4 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2024Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
7675363 | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
59605000 | usd |
CY2023Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
60476000 | usd |
CY2023Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
11000 | usd |
CY2023Q3 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
10000 | usd |
CY2023Q4 | us-gaap |
Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
|
2155000 | usd |
CY2023Q3 | us-gaap |
Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
|
2046000 | usd |
CY2023Q4 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
264000 | usd |
CY2023Q3 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
253000 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
603000 | usd |
CY2023Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
669000 | usd |
CY2023Q4 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
251000 | usd |
CY2023Q3 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
247000 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
62889000 | usd |
CY2023Q3 | us-gaap |
Assets Current
AssetsCurrent
|
63701000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
282000 | usd |
CY2023Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
305000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
206000 | usd |
CY2023Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
295000 | usd |
CY2023Q4 | us-gaap |
Indefinite Lived Contractual Rights
IndefiniteLivedContractualRights
|
81466000 | usd |
CY2023Q3 | us-gaap |
Indefinite Lived Contractual Rights
IndefiniteLivedContractualRights
|
81262000 | usd |
CY2023Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
163000 | usd |
CY2023Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
156000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
145006000 | usd |
CY2023Q3 | us-gaap |
Assets
Assets
|
145719000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1616000 | usd |
CY2023Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
3165000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
186000 | usd |
CY2023Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
279000 | usd |
CY2023Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
978000 | usd |
CY2023Q3 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
748000 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2780000 | usd |
CY2023Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4192000 | usd |
CY2023Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
39240000 | usd |
CY2023Q3 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
39164000 | usd |
CY2023Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
14825000 | usd |
CY2023Q3 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
14611000 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
56845000 | usd |
CY2023Q3 | us-gaap |
Liabilities
Liabilities
|
57967000 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
22064000 | usd |
CY2023Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
21800000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
66097000 | usd |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
65952000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
88161000 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
87752000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
145006000 | usd |
CY2023Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
145719000 | usd |
CY2023Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
6144000 | usd |
CY2022Q4 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
6145000 | usd |
CY2023Q4 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
1866000 | usd |
CY2022Q4 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
1858000 | usd |
CY2023Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1724000 | usd |
CY2022Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1569000 | usd |
CY2023Q4 | hnna |
Distribution Expense
DistributionExpense
|
149000 | usd |
CY2022Q4 | hnna |
Distribution Expense
DistributionExpense
|
95000 | usd |
CY2023Q4 | us-gaap |
Subadvisory Fees For Mutual Funds
SubadvisoryFeesForMutualFunds
|
911000 | usd |
CY2022Q4 | us-gaap |
Subadvisory Fees For Mutual Funds
SubadvisoryFeesForMutualFunds
|
969000 | usd |
CY2023Q4 | us-gaap |
Depreciation
Depreciation
|
69000 | usd |
CY2022Q4 | us-gaap |
Depreciation
Depreciation
|
49000 | usd |
CY2023Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
4719000 | usd |
CY2022Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
4540000 | usd |
CY2023Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1425000 | usd |
CY2022Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1605000 | usd |
CY2023Q4 | us-gaap |
Interest Expense
InterestExpense
|
567000 | usd |
CY2022Q4 | us-gaap |
Interest Expense
InterestExpense
|
563000 | usd |
CY2023Q4 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
786000 | usd |
CY2022Q4 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
467000 | usd |
CY2023Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1644000 | usd |
CY2022Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1509000 | usd |
CY2023Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
444000 | usd |
CY2022Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
390000 | usd |
CY2023Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1200000 | usd |
CY2022Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1119000 | usd |
CY2023Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.16 | |
CY2022Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.15 | |
CY2023Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.16 | |
CY2022Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.15 | |
CY2023Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7672191 | |
CY2022Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7572454 | |
CY2023Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7673688 | |
CY2022Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7581157 | |
CY2023Q4 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.14 | |
CY2022Q4 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.14 | |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
87752000 | usd |
CY2023Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1200000 | usd |
CY2023Q4 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
1055000 | usd |
CY2023Q4 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
246000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
88161000 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
86298000 | usd |
CY2022Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1119000 | usd |
CY2022Q4 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
1041000 | usd |
CY2022Q4 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
262000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
86655000 | usd |
CY2023Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1200000 | usd |
CY2022Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1119000 | usd |
CY2023Q4 | us-gaap |
Depreciation
Depreciation
|
69000 | usd |
CY2022Q4 | us-gaap |
Depreciation
Depreciation
|
49000 | usd |
CY2023Q4 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
1000 | usd |
CY2022Q4 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
1000 | usd |
CY2023Q4 | hnna |
Change In Right Of Use Asset And Operating Lease Liability
ChangeInRightOfUseAssetAndOperatingLeaseLiability
|
-4000 | usd |
CY2022Q4 | hnna |
Change In Right Of Use Asset And Operating Lease Liability
ChangeInRightOfUseAssetAndOperatingLeaseLiability
|
-1000 | usd |
CY2023Q4 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
76000 | usd |
CY2022Q4 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
73000 | usd |
CY2023Q4 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
214000 | usd |
CY2022Q4 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
262000 | usd |
CY2023Q4 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
246000 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
262000 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
|
109000 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
|
24000 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
11000 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
78000 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-66000 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-169000 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
4000 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
|
-0 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
7000 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
1000 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-1549000 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-1989000 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
230000 | usd |
CY2022Q4 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
128000 | usd |
CY2023Q4 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
416000 | usd |
CY2022Q4 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-32000 | usd |
CY2023Q4 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
46000 | usd |
CY2022Q4 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
64000 | usd |
CY2023Q4 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
204000 | usd |
CY2022Q4 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
317000 | usd |
CY2023Q4 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-250000 | usd |
CY2022Q4 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-381000 | usd |
CY2023Q4 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
1038000 | usd |
CY2022Q4 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
1026000 | usd |
CY2023Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1037000 | usd |
CY2022Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1024000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations
|
-871000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations
|
-1437000 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
60476000 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
58487000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
59605000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
57050000 | usd |
CY2023Q4 | us-gaap |
Interest Paid Net
InterestPaidNet
|
491000 | usd |
CY2022Q4 | us-gaap |
Interest Paid Net
InterestPaidNet
|
491000 | usd |
CY2023Q4 | us-gaap |
Stock Issued1
StockIssued1
|
17000 | usd |
CY2022Q4 | us-gaap |
Stock Issued1
StockIssued1
|
15000 | usd |
CY2023Q4 | hnna |
Management Contracts Purchased Textblock
ManagementContractsPurchasedTextblock
|
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><b>(<em style="font: inherit;">2</em>)</b></p> </td><td style="width: auto;"> <p style="margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><b>Management Contracts Purchased</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Throughout its history, the Company has completed 12 purchases of the assets related to the management of 32 investment funds, some of which were reorganized into already existing Hennessy Funds. In accordance with Financial Accounting Standards Board (“FASB”) guidance, the Company periodically reviews the carrying value of its management contracts asset to determine if any impairment has occurred. The fair value of the management contracts asset was estimated as of <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2023,</em> by applying the income approach and is based on management estimates and assumptions, including third‑party valuations that utilize appropriate valuation techniques. It was determined there was no impairment as of such date. As of <em style="font: inherit;"> December 31, 2023</em>, management performed a qualitative analysis and determined it was more likely than <em style="font: inherit;">not</em> that there continued to be no impairment.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Under Accounting Standards Codification <em style="font: inherit;">350</em> — Intangibles - Goodwill and Other, intangible assets that have indefinite useful lives are <em style="font: inherit;">not</em> amortized but are tested at least annually for impairment. The Company considered various factors, such as likelihood of continued renewal, whether there are foreseeable limits on net cash flows, and whether the Company is dependent on a limited number of investors, in determining the useful life of the management contracts. Based on analysis, the Company considers the management contract asset to be an intangible asset with an indefinite useful life and <em style="font: inherit;">no</em> impairment as of the end of the current period. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Company completed its most recent asset purchase on <em style="font: inherit;"> November </em><em style="font: inherit;">10,</em> <em style="font: inherit;">2023,</em> when it purchased assets related to the management of the CCM Small/Mid-Cap Impact Value Fund. This asset purchase added approximately $12 million to the Company’s assets under management at the time of closing. The purchase was consummated in accordance with the terms and conditions of that certain Transaction Agreement, dated as of <em style="font: inherit;"> April 26, 2023, </em>between the Company and Community Capital Management, LLC (the “CCM Transaction Agreement”). Upon completion of the transaction, the assets of CCM Small/Mid-Cap Impact Value Fund were reorganized into the Hennessy Stance ESG ETF.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">As of <em style="font: inherit;"> December 31, 2023, </em>there was a <em style="font: inherit;">second</em> asset purchase pending under the CCM Transaction Agreement, which is for the purchase of assets related to the management of the CCM Core Impact Equity Fund. The purchase is subject to customary closing conditions, including the approval of the shareholders of the CCM Core Impact Equity Fund. At the Special Meeting of Shareholders of the CCM Core Impact Equity Fund on <em style="font: inherit;"> January 31, 2024, </em>shareholders approved the purchase of assets related to the management of the CCM Core Impact Equity Fund by the Company. See Note <em style="font: inherit;">13,</em> "Subsequent Events," for additional information.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">In the current period, the Company capitalized $0.2 million in legal costs related to the CCM Transaction Agreement. </p> | |
CY2023Q4 | hnna |
Number Of Purchases Of Assets
NumberOfPurchasesOfAssets
|
12 | pure |
CY2023Q4 | hnna |
Number Of Investment Funds
NumberOfInvestmentFunds
|
32 | pure |
CY2023 | hnna |
Management Contracts Purchased Impairment
ManagementContractsPurchasedImpairment
|
0 | usd |
CY2023Q4 | hnna |
Management Contracts Purchased Impairment
ManagementContractsPurchasedImpairment
|
0 | usd |
CY2023Q4 | hnna |
Number Of Open End Mutual Funds
NumberOfOpenEndMutualFunds
|
16 | pure |
CY2023Q4 | hnna |
Notice Period For Termination Of Agreement
NoticePeriodForTerminationOfAgreement
|
P60D | |
CY2023Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
59417000 | usd |
CY2023Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
59417000 | usd |
CY2023Q3 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
59392000 | usd |
CY2023Q3 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
59392000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
206000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
186000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
0 | usd |
CY2023Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P0Y7M6D | |
CY2023Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.009 | pure |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
191000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
191000 | usd |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
5000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
186000 | usd |
CY2023Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
554000 | usd |
CY2023Q3 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
2260000 | usd |
CY2023Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
317000 | usd |
CY2023Q3 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
310000 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
745000 | usd |
CY2023Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
595000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1616000 | usd |
CY2023Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
3165000 | usd |
CY2023Q4 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.27 | pure |
CY2022Q4 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.258 | pure |
CY2023Q4 | us-gaap |
Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
|
40000.00 | usd |
CY2022Q4 | us-gaap |
Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
|
30000.00 | usd |
CY2023Q4 | us-gaap |
Other Commitment
OtherCommitment
|
0 | usd |
CY2023Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7672191 | |
CY2022Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7572454 | |
CY2023Q4 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1497 | |
CY2022Q4 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
8703 | |
CY2023Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7673688 | |
CY2022Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7581157 | |
CY2023Q4 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.1375 |